Similarly, this genotype is protective in non-alcoholic fatty liver disease (NAFLD): A/A homozygosity was associated to a lower rate of significant fibrosis and to a lower liver expression of MerTK. This evidence concerns the gene MERTK and metabolic dysfunction-associated steatotic liver disease.